ARKG vs BOTZ.
ARK Genomic Revolution ETF (Active — genomics equities) against Global X Robotics & Artificial Intelligence ETF (Indxx Global Robotics & AI Thematic) — fees, long-horizon total returns, holdings overlap, and sector tilt, side by side.
Daily bar history for this pair isn’t loaded yet — returns will appear once the nightly ingest covers both funds.
| ARKG | BOTZ | |
|---|---|---|
| Name | ARK Genomic Revolution ETF | Global X Robotics & Artificial Intelligence ETF |
| Category | Health | Technology |
| Style | Active | Passive |
| Expense ratio | 0.75% | 0.68% |
| Assets (AUM) | $1.7B | $3.5B |
| Dividend yield | 0.00% | 0.47% |
| Avg volume (3-mo) | 3.3M | 1.0M |
| Inception | October 31, 2014 | September 12, 2016 |
| Benchmark proxy | S&P 500 | S&P 500 |
BOTZ costs 0.07 pp less per year — about $7.00 per $10,000 invested.
Expense ratios verified against issuer fact sheets. Dividend yield is trailing 12-month distributions divided by price, as reported by the fund data provider.
Sum of min(weight in each fund) across shared tickers — the standard fund-overlap measure. Computed on the top 25 holdings each fund reports, so it is a lower bound; the coverage figures show how much of each fund those top holdings represent.